Thus, we have found that mice carrying a Vav2 mutant protein with reduced catalytic activity exhibit impaired IGF1- and insulin-mediated PI3Kα signaling, reduced muscle mass, and increased glucose intolerance (Supplementary Fig. 18a). This evidence concerns the gene VAV2 and Glucose intolerance.